Our people
What we do
Industries Practices Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy and Natural Resources

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Mobility and Transportation

Private Capital

Real Estate

Sports, Media and Entertainment

Technology and Telecoms

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property, Media, and Technology

Regulatory
Case studies
Our thinking
ESG
Join us

Search

Search

Deutsch
English
Español
Français
中文
日本語

About us
Where we are
Media center
Events and webinars
Responsible Business
Alumni

Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Resources

Supply Chains

Access our latest insights into supply chain risk management and governance.

Distressed Banks

Navigate the legal implications relating to banks in distress with our resource center.

Premium services

Click here to learn more about our range of premium tools

Comparative guides

View the global picture with our interactive comparative guides

Publications

Search

No results found

0

Filter by type

News

Financial Institutions
Life Sciences and Health Care

Antitrust and Competition
Health
Intellectual Property
International Trade Commission Section 337
IP and Technology Transactions
Medical Device and Technology Regulatory
Patents
Pharmaceuticals and Biotechnology Regulatory
Privacy and Cybersecurity

UK2030: defining a path to global business competitiveness

2023
2022
2021

Brussels
Dublin
London

News

CMA issues statement on permitted collaboration to assist provision of combination therapies to NHS

24 November 2023

The UK CMA has published practical guidance confirming its commitment to ensuring that competition law does not hinder collaborations between medicine manufacturers which aim to make...

News

To opt out or not to opt out, that is the question………

11 October 2022

'Go live’ of Unitary Patents and the corresponding Unified Patent Court (UPC) system in the EU is imminent. The UPC system has particular relevance to life sciences and technology ...

News

Safety first: MHRA response to UK medical device regulation consultation

01 July 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to its consultation on the future regulation of medical devices in the United Kingdom which ran...

News

Emerging AI issues affecting EU, UK life sciences firms

15 June 2022

At our recent Health Care AI Law and Policy Summit, Hogan Lovells attorneys Dan Whitehead, Bonella Ramsay, Louise Crawford, and Imogen Ireland convened with industry leaders virtually at...

News

UK ABPI transfer of value disclosures: transitioning from consent to legitimate interests

24 November 2021

UK pharmaceutical companies have historically relied upon consent as the lawful basis for the disclosure of healthcare professionals’ personal data relating to transfers of value....

Load more

Stay in the know Subscribe

Connect with us

Quick Links

Our people
Case studies
Our thinking

Responsible Business
Diversity, Equity & Inclusion

About us
Join us
Contact us

Cookies
Disclaimer
Legal notices
Modern Slavery Statement
Privacy
RSS

© 2024 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.